• Je něco špatně v tomto záznamu ?

Cholesterol and glucose profiles according to different fasting C-peptide levels: a cross-sectional analysis in a healthy cohort from the Czech Republic

Vladimír Kron, Miroslav Verner, Ladislav Pešl, Pavel Smetana, Jaromír Kadlec, Daniel Martiník

. 2021 ; 19 (4) : 220-227.

Jazyk angličtina Země Česko

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22007636

The relationship between glycaemia and lipoprotein metabolism has not been completely clarified, and slight differences may be found between local authors, trials and evaluated parameters. Therefore this cross-sectional study investigated fasting cholesterol and glucose levels along with the determination of atherogenic index in a cohort of healthy individuals from the Czech Republic in relation to their fasting C-peptide levels. Data were collected between 2009 and 2018 and a total of 3189 individuals were stratified by C-peptide reference range (260-1730 pmol/l) into three groups - below (n = 111), within (n = 2952) and above (n = 126). Total, HDL, LDL cholesterol and atherogenic index were used to compare lipoprotein levels by relevant C-peptide concentrations. Participants using the supplements to affect lipid or glycaemia metabolism were excluded from this study. The evaluation of blood parameters in a fasting state included correlations between C-peptide and cholesterols, differences of variances (F-test) and the comparison of lipoprotein mean values (t-test) between the groups created by the C-peptide reference range. Mean values of total (4.9, 5.1, 5.3 mmol/l), LDL (2.6, 3.1, 3.4 mmol/l) cholesterol and atherogenic index (2.1, 2.8, 3.7) were higher with increasing C-peptide levels, whereas HDL was inversely associated with fasting C-peptide concentration. A positive and negative correlation between atherogenic index (rxy = 0.36) and HDL level (rxy = -0.36) with C-peptide values was found. Differences of HDL, LDL and atherogenic index were, in particular, recorded between the groups below and above the reference range of C-peptide (p ≤ 0.001). Considerable differences (p ≤ 0.001) were also observed for the same lipoprotein characteristics between the groups above and within the C-peptide reference. Generally, the type of cholesterol is crucial for the evaluation of specific changes concerning the C-peptide range. Lipoprotein concentrations differ in relation to C-peptide - not only below and above the physiological range, but also inside and outside of it.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22007636
003      
CZ-PrNML
005      
20220914110742.0
007      
ta
008      
220306s2021 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.32725/jab.2021.023 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Kron, Vladimír $7 xx0258956 $u University of South Bohemia, Faculty of Agriculture, Department of Food Biotechnologies and Agricultural Products Quality, České Budějovice, Czech Republic; Clinic for Metabolic Assessment of prof. MUDr. Karel Martiník, DrSc., s.r.o., Hradec Králové, Czech Republic; University of South Bohemia, Faculty of Science, Department of Medical Biology, České Budějovice, Czech Republic
245    10
$a Cholesterol and glucose profiles according to different fasting C-peptide levels: a cross-sectional analysis in a healthy cohort from the Czech Republic / $c Vladimír Kron, Miroslav Verner, Ladislav Pešl, Pavel Smetana, Jaromír Kadlec, Daniel Martiník
504    __
$a Literatura
520    9_
$a The relationship between glycaemia and lipoprotein metabolism has not been completely clarified, and slight differences may be found between local authors, trials and evaluated parameters. Therefore this cross-sectional study investigated fasting cholesterol and glucose levels along with the determination of atherogenic index in a cohort of healthy individuals from the Czech Republic in relation to their fasting C-peptide levels. Data were collected between 2009 and 2018 and a total of 3189 individuals were stratified by C-peptide reference range (260-1730 pmol/l) into three groups - below (n = 111), within (n = 2952) and above (n = 126). Total, HDL, LDL cholesterol and atherogenic index were used to compare lipoprotein levels by relevant C-peptide concentrations. Participants using the supplements to affect lipid or glycaemia metabolism were excluded from this study. The evaluation of blood parameters in a fasting state included correlations between C-peptide and cholesterols, differences of variances (F-test) and the comparison of lipoprotein mean values (t-test) between the groups created by the C-peptide reference range. Mean values of total (4.9, 5.1, 5.3 mmol/l), LDL (2.6, 3.1, 3.4 mmol/l) cholesterol and atherogenic index (2.1, 2.8, 3.7) were higher with increasing C-peptide levels, whereas HDL was inversely associated with fasting C-peptide concentration. A positive and negative correlation between atherogenic index (rxy = 0.36) and HDL level (rxy = -0.36) with C-peptide values was found. Differences of HDL, LDL and atherogenic index were, in particular, recorded between the groups below and above the reference range of C-peptide (p ≤ 0.001). Considerable differences (p ≤ 0.001) were also observed for the same lipoprotein characteristics between the groups above and within the C-peptide reference. Generally, the type of cholesterol is crucial for the evaluation of specific changes concerning the C-peptide range. Lipoprotein concentrations differ in relation to C-peptide - not only below and above the physiological range, but also inside and outside of it.
650    _7
$a ateroskleróza $x epidemiologie $x metabolismus $7 D050197 $2 czmesh
650    17
$a C-peptid $x analýza $x metabolismus $7 D002096 $2 czmesh
650    _7
$a krevní glukóza $x analýza $x metabolismus $7 D001786 $2 czmesh
650    _7
$a LDL-cholesterol $x analýza $x metabolismus $7 D008078 $2 czmesh
650    _7
$a omezení příjmu potravy $x krev $x metabolismus $7 D005215 $2 czmesh
650    _7
$a průřezové studie $x statistika a číselné údaje $7 D003430 $2 czmesh
650    _7
$a mladý dospělý $7 D055815 $2 czmesh
650    _7
$a lidé středního věku $7 D008875 $2 czmesh
650    _7
$a lidé $7 D006801 $2 czmesh
650    _7
$a senioři $7 D000368 $2 czmesh
650    _7
$a dospělí $7 D000328 $2 czmesh
650    _7
$a mladiství $7 D000293 $2 czmesh
655    _7
$a práce podpořená grantem $7 D013485 $2 czmesh
700    1_
$a Verner, Miroslav, $d 1959- $7 jn20000402513 $u Hospital of České Budějovice, a. s., Central Laboratories, České Budějovice, Czech Republic; University of South Bohemia, Faculty of Health and Social Sciences, Institute of Laboratory Diagnostics, České Budějovice, Czech Republic
700    1_
$a Pešl, Ladislav, $d 1964- $7 xx0103342 $u Hospital of České Budějovice, a. s., Cardiovascular and Thoracic Center, České Budějovice, Czech Republic
700    1_
$a Smetana, Pavel, $d 1963- $7 mzk2009521636 $u University of South Bohemia, Faculty of Agriculture, Department of Food Biotechnologies and Agricultural Products Quality, České Budějovice, Czech Republic
700    1_
$a Kadlec, Jaromír, $d 1967 srpen 21.- $7 uzp2006361327 $u University of South Bohemia, Faculty of Agriculture, Department of Food Biotechnologies and Agricultural Products Quality, České Budějovice, Czech Republic
700    1_
$a Martiník, Daniel $7 xx0270353 $u Clinic for Metabolic Assessment of prof. MUDr. Karel Martiník, DrSc., s.r.o., Hradec Králové, Czech Republic
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 19, č. 4 (2021), s. 220-227 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/ $y stránka časopisu
910    __
$a ABA008 $b B 2301 $c 1249 $y p $z 0
990    __
$a 20220304160729 $b ABA008
991    __
$a 20220914110738 $b ABA008
999    __
$a ok $b bmc $g 1767397 $s 1158825
BAS    __
$a 3
BMC    __
$a 2021 $b 19 $c 4 $d 220-227 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK125 $d 20220914 $a NLK 2022-11/dk

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...